Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03333837 · ClinicalTrials.gov registry record · NA

Improvisational Movement for People With Memory Loss and Their Caregivers

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
104
Enrollment target

NCT03333837: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT03333837 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03333837, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target

Study Summary

Dementia is a progressive decline in cognition that impairs a person's ability to perform activities of daily living. Changes in mood, gait, and balance are prominent secondary symptoms of Alzheimer's dementia that can dramatically decrease quality of life for the person with dementia and increase caregiver burden. The overall aim of this study is to determine the independent and combined effects of dance movement and social engagement on quality of life in people with early-stage dementia, and test the neural mechanisms of these effects.

Primary Outcome

Self-reported quality of life in the person with dementia is the primary outcome and will be measured using the QOL-AD . The QOL-AD is validated for use in people with Mini Mental State Exam scores as low as 10.The QOL\_AD contains 13 items.Points are assigned to each item as follows: poor = 1, fair = 2, good = 3, excellent = 4.The total score is the sum of all 13 item (range 13- 52) higher scores represent better outcomes.

Interventions

  • BEHAVIORAL Dance Group
  • BEHAVIORAL Non-Group Dance
  • BEHAVIORAL Social Group
  • BEHAVIORAL No Contact

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2018-02-06
Est. Completion 2021-05-26
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT03333837 record still lists

NCT03333837 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 4 interventions - of which Dance Group is the first listed.

NCT03333837 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03333837 about?

NCT03333837 is a clinical study titled "Improvisational Movement for People With Memory Loss and Their Caregivers". Dementia is a progressive decline in cognition that impairs a person's ability to perform activities of daily living. Changes in mood, gait, and balance are prominent secondary symptoms of Alzheimer's dementia that can dramatically decrease quality of life for the person with dementia and increase c...

What is the current status of trial NCT03333837?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2018-02-06. Estimated completion is 2021-05-26.

What interventions are being tested in trial NCT03333837?

The interventions under investigation include: Dance Group (BEHAVIORAL), Non-Group Dance (BEHAVIORAL), Social Group (BEHAVIORAL), No Contact (BEHAVIORAL).

Who is sponsoring clinical trial NCT03333837?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03333837's enrollment target sits among peer trials

104 836th of 2000 higher than 1,164 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03333837, the US trial registry maintained by the National Library of Medicine. NCT03333837 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.